echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > What is the market performance of Chinese patent medicine with the second largest share?

    What is the market performance of Chinese patent medicine with the second largest share?

    • Last Update: 2017-10-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [market analysis of chinapharma.com] according to the blue book of China's six terminal drug markets published by Zhongkang information, in 2016, chemical drugs accounted for 49.3% of drug sales, Chinese patent drugs accounted for 47.2%, and biological products only accounted for 3.5% Recently, in the article "120.7 billion retail drugstore chemical drug market, four categories account for more than 60% of the market data", Xinkangjie introduced the retail drugstore chemical drug market in detail, so how about the market performance of the second largest Chinese patent drug market? Overall situation: according to the monitoring data of Zhongkang CMH, in 2016, the annual sales of five categories in the national retail drugstore market exceeded 10 billion, accounting for 94% of the total market Among them, the scale of respiratory system drugs is large, 39.2 billion yuan, up 6.6% year-on-year, with a market share of 34%; the other four categories are digestive system and metabolic drugs, reproductive urinary system and sexual hormone drugs, cardiovascular system drugs and muscle bone system drugs, with a year-on-year growth rate of 13.9% 1 Chinese patent medicine for respiratory system in 2016, the overall market scale of Chinese patent medicine for respiratory system increased by 6.6% year on year, from 36.8 billion yuan in 2015 to 39.2 billion yuan, while the market share decreased by 0.4 percentage points year on year, to 33.9% According to the CMH monitoring data of Zhongkang, in the Chinese patent medicine market of respiratory system medicine, the top ten varieties are cough and cold medicine, accounting for 30.0% of the total; the anti-inflammatory effect of pudilian blue rose year on year, replacing the top of Ganmaoling, with the main effects of clearing heat and detoxification, anti-inflammatory and detumescence; it can be used for boils, pharyngitis, tonsillitis, etc Ganmaoling has the effect of antipyretic and analgesic It is used for headache, fever, stuffy nose, runny nose, sore throat, etc caused by cold In 2016, its share decreased year on year 2 Chinese patent medicine for digestive system and metabolism in 2016, the total market size of Chinese patent medicine for digestive system and metabolism was RMB 25.5 billion, an increase of 13.9% compared with that of 2015, and the market share was also increased by 1.2 percentage points year on year In 2016, the total share of top 10 in the Chinese patent medicine market of digestive system and metabolism drugs was 51.8% Ejiao, a nourishing medicine, has a unique market share of nearly 30% The following compound donkey hide gelatin is a tonic, with outstanding market performance, and its share increased to 6.0% from 2.8% last year 3 Chinese patent medicines for genitourinary system and sex hormones According to the monitoring data of Zhongkang CMH, the market scale of Chinese patent medicines for genitourinary system and sex hormones in retail pharmacies in 2016 was 17.1 billion yuan, up 5.8% year on year However, the market share declined by 0.3 points In 2016, the total share of top 10 categories was 42.4%, and the total share of Liuwei Dihuang, Shenbao, ancient Han health care, Sanjin and other urinary system drugs was 27.9% Among them, Shenbao showed outstanding performance, with a year-on-year increase of 1.4% Jieeryin, Fuyankang, fuqianjin and Xiaomi are all anti infective and antibacterial agents for gynecology, but the proportion of Fuyankang is not high 4 The total market scale of Chinese patent medicine for cardiovascular system in the Chinese patent medicine market in 2016 was 14 billion yuan, with a year-on-year growth of 9.2%, and the share also increased by 0.2%, showing a good market performance According to the CMH monitoring data of Zhongkang, in the Chinese patent medicine market of cardiovascular system drugs in 2016, among the top ten varieties, except Angong Niuhuang, Xuesaitong and Naoxintong, all the other seven varieties were used for heart disease treatment Compound Danshen Tablets led the market with 11.5% of the market share, with 0.6 points lost year-on-year Compared with the same period last year, Danshen Baoxin's share increased by 0.6 points 5 Musculoskeletal system Chinese patent medicine according to the monitoring data of Zhongkang CMH, the total market scale of musculoskeletal system Chinese patent medicine in 2016 was 13.2 billion yuan, which was the slow growth category among the five categories, with a growth rate of 4.1% and a market share of 11.4% According to the CMH monitoring data of Zhongkang, in 2016, Yunnan Baiyao group used Yunnan Baiyao aerosol, Yunnan Baiyao ointment and Yunnan Baiyao Powder, as well as anti-inflammatory and anti wind dampness drugs Yunnan Baiyao capsule and Yunnan Baiyao tincture, accounting for 14.6% of the total, basically stable with 15 years Hongmao, an anti-inflammatory drug and an anti rheumatic drug, ranked next with a respectable market performance, with a year-on-year growth of 1.5 points Job's job is better in the top 10 market, which is also an anti-inflammatory drug and an anti rheumatic drug Original title: the retail market scale of five Chinese patent medicines exceeds 10 billion, accounting for 94% of the total market share We will teach you to use app (Pharma) to seize the opportunity of pharmaceutical machinery
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.